1. Dilek S, Pata O, Tok E, Polat A. Extraovarian nongestational choriocarcinoma in a postmenopausal woman. Int J Gynecol Cancer. 2004. 14:1033–1035.
2. O'Neill CJ, Houghton F, Clarke J, McCluggage WG. Uterine gestational choriocarcinoma developing after a long latent period in a postmenopausal woman: the value of DNA polymorphism studies. Int J Surg Pathol. 2008. 16:226–229.
3. Sonobe H, Taguchi K, Ogawa K, Yoshioka T. Latent vaginal choriocarcinoma in a postmenopausal woman. Acta Pathol Jpn. 1976. 26:611–618.
4. Savage P. Hancock BW, Seckl MJ, Berkowitz RS, Cole LA, editors. Clinical features of molar pregnancies and gestational trophoblastic neoplasia. Gestational trophoblastic disease. 2011. 3rd ed. 216–248.
5. Small W Jr, Lurain JR, Shetty RM, Huang CF, Applegate GL, Brand WN. Gestational trophoblastic disease metastatic to the brain. Radiology. 1996. 200:277–280.
6. Mastrodomenico I, Korobkin M, Silverman PM, Dunnick NR. Perinephric hemorrhage from metastatic carcinoma to the kidney. J Comput Assist Tomogr. 1983. 7:727–729.
7. Wang YE, Song HZ, Yang XY, Dong SY, Gan N. Renal metastasis of choriocarcinoma. A clinicopathological study of 31 cases. Chin Med J. 1991. 104:716–720.
8. Ngan HY, Benedet JL, Jones HW III, Bender HG, Pecorelli S. FIGO Staging and risk factor scoring for trophoblastic neoplasia. Int J Gynecol Obstet. 2002. 77:285–287.
9. Alazzam M, Tidy J, Hancock BW, Osborne R. First line chemotherapy in low risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2009. 1:CD007102.
10. Lurain JR, Singh DK, Schink JC. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med. 2006. 51:773–776.